Product Description
In the treatment of pneumocystis carinii pneumonia, Co-trimoxazole Tablets is first choice. Used Co-trimoxazole Tablets to the treatment of Streptococcus pneumoniae and haemophilus lead to acute otitis media for 2 years age or older children. E. coli, klebsiella species, e. coli and proteus, ordinary proteus and Morgan bacterial urinary tract infections caused by susceptible strains.
Drug Name
Generic name. Co-trimoxazole Tablets
English name. Co-trimoxazole Tablets
Antifungal Co-trimoxazole Tablets Indications
The main indications of this product is to treatment the following infections caused by susceptible strains.
1. E. coli, klebsiella species, e. coli and proteus, ordinary proteus and Morgan bacterial urinary tract infections caused by susceptible strains.
2. Streptococcus pneumoniae and haemophilus lead to acute otitis media for 2 years age or older children.
3. Streptococcus pneumoniae and haemophilus lead to adult chronic bronchitis acute episodes.
4. In the treatment of pneumocystis carinii pneumonia, this product is first choice.
5. Pneumocystis carinii pneumonia prevention, available for pneumocystis carinii disease patients to hae a history of at least one, or adults infected with HIV, their CD4 lymphocyte count 200 cells/mm3 or less or less than 20% of the total number of lymphocytes.
6. Enterotoxin e. coli (ETEC) lead to tourists diarrhea.
Specification
480 mg
Quality Standard
BP
Packaging
10 x 10 tablets/box
Preparations
tablets, suspension, syrup etc.
